Introduction
There is a growing body of evidence that physical performance is influenced at a minimum by environmental and genetic factors. The latter group includes genes and other DNA sequences that are implicated in human physiology and body composition. Natural variants, or alleles, of the candidate genes have been identified in the general population in the past two decades and shown to influence exercise performance [1] .
The β1-adrenergic receptor gene (Entrez Gene: ADRB1) is likely to be a candidate because it has been suggested to influence exercise capacity and contribute to the regulation of the cardiovascular system [2, 3] . ADRB1 encodes the β1-adrenergic receptor (β1AR) protein, which is a member of catecholaminestimulated family of adrenergic receptors (ARs). When the β1ARs are activated by an agonist, they interact with a G-protein, activate the adenylyl cyclase (AC) and ultimately promote the production of cAMP. The β1-adrenergic receptors are expressed in a large Abstract: Background: The ADRB1 gene encodes the β1-adrenergic receptor and is thought to influence exercise capacity because of its contribution to the regulation of the cardiovascular system. The aim of the study was to determine the distribution of the ADRB1 genotypes Ser49Gly and Arg389Gly and identify the haplotypes within a group of Polish athletes to investigate the possible association between genetic polymorphisms in ADRB1 and athletic performance. Methodology: 223 Polish athletes and 354 volunteers were recruited for this study.
All samples were genotyped using an allelic discrimination assay. Results: The frequencies of the 49Gly allele and the 49Gly:Arg389 haplotype were significantly higher in the subgroup of endurance athletes than in the controls (11% vs. 6.4%, P=0.026; 11% vs. 6.3%, P=0.048 for 49Gly allele and 49Gly:Arg389 haplotype, respectively). The odds ratio of having the 49Gly allele vs. Ser49/Ser49 genotype for endurance athletes was 2.00 (95% CI: 1.16-3.47; P=0.018). In the Polish athletes, the odds ratio of the ADRB1 49Gly:Arg389 haplotype for endurance athletes subgroup was 1.82 (95% confidence interval 1.10-3.00; P=0.026).
Conclusions:
Ser49Gly spectrum of cells, including vascular smooth muscle, epithelium, adipocytes and cardiomyocytes. Stimulated β1ARs actively participate in the regulation of the heart rate and contractility by increasing inotropy and chronotropy in the arteries.
The intronless ADRB1 gene is located on chromosome 10 (10q24-q26). Within the sequence of ADRB1, more than 100 single nucleotide polymorphisms (SNPs) exist. However, only two non-synonymous SNPs have been found to be functionally relevant [4, 5] . The first, located in position 145 of the gene sequence and commonly referred to as Ser49Gly (rs1801252), causes a substitution of serine (AGC) by glycine (GGC) at amino acid position 49. The second polymorphism, situated at position 1165 of the gene and referred to as Arg389Gly (rs1801253), replaces arginine (CGA) with glycine (GGA) at amino acid position 389 [6] . Many attempts have been made to determine the associations of these polymorphisms and their prevalence with the severity or progression of cardiovascular diseases, including chronic heart failure, hypertension and coronary artery disease, and divergent results have been described regarding the functional relevance of the Ser49Gly and Arg389Gly polymorphisms [7] [8] [9] [10] .
Because β1-adrenergic receptors are key elements of a cardiac and vascular regulation system and may be regarded as a crucial component that influences cardiac output and overall aerobic capacity, we proposed that variants of Ser49Gly and Arg389Gly in the ADRB1 that are of functional relevance could be regarded alone or/and in haplotypes as performance enhancing polymorphisms in endurance athletes. Therefore, the aim of this study was to determine the distribution of the ADRB1 SNP genotypes and to identify the haplotypes within a group of Polish athletes to investigate the possible association between genetic polymorphisms in ADRB1 and athletic performance.
Experimental Procedures
The experimental procedures have been conducted in accordance with the set of guiding principles for reporting results of genetic association studies defined by STrengthening the REporting of Genetic Association studies (STREGA) Statement [11, 12] .
Participants
The study was done in a group of 225 Polish current and former professional athletes, aged 19-41, of the highest nationally competitive standard (male n=158 and female n=67). The athlete sample size was limited because we wanted to ensure that all of these subjects were at the upper end of the human power and endurance performance continuum. Thus, the group of athletes comprised two subgroups:
1. endurance athletes (n=124; male=100, female=24) characterized by predominant aerobic energy production (duration of exertion over 5 minutes, intensity of exertion moderate to high). This group included triathletes (n=5) who were performing swimming (1,500 m), cycling (40 km) and running (10 km), race walkers (n=6), road cyclists (n=14), 15-50 km cross-country skiers (n=6), marathon runners (n=12), rowers (n=53), 3-10 km runners (n=17) and 800-1500 m swimmers (n=11); 2. power athletes (n=101; male=58, female=43) with predominantly anaerobic energy production (duration of exertion <1 minute, intensity of exertion submaximal to maximal): 100-400 m runners (n=29), powerlifters (n=23), weightlifters (n=20), throwers (n=14) and jumpers (n=15).
All Polish athletes recruited for this study were ranked in the top 10 nationally in their respective discipline. The study population was stratified using the classification described by Druzhevskaya et al. [13] . The athletes included 48 athletes classified as 'top-elite' (gold medallists in the World and European Championships, World Cups or Olympic Games) and 106 athletes classified as 'elite' (silver or bronze medallist in the World and European Championships, World Cups or Olympic Games). The others (n=71) were classified as 'sub-elite' (participants in international competitions). Various methods were used to obtain the samples, including: targeting national teams and providing information to national coaching staff and athletes attending training camps.
Control samples were prepared from 357 unrelated volunteers (students of the University of Szczecin, aged 19-23; 82 females and 275 males). Control subjects were required to be sedentary, defined as not presently engaged in regular physical activity. Control volunteers have filled a questionnaire and reported to be nonathletic (have not participated in any professional sport competitions as well as have not been members of any sport clubs). All control subjects and athletes were of the same ethnic group to reduce the possibility of racial gene skew and to overcome any potential problems due to population stratification. The procedures followed in the study were conducted ethically according to the principles of the World Medical Association Declaration of Helsinki and ethical standards in sport and exercise science research. All procedures were approved by the Pomeranian Medical University Ethics Committee. All participants gave informed consent to genotyping with the understanding that it was anonymous and obtained results would be confidential.
Genetic analyses
The buccal cells donated by the participants were collected in Resuspension Solution (GenElute Mammalian Genomic DNA Miniprep Kit, Sigma, Germany) with the use of sterile foam-tipped applicators (Puritan, USA). All samples were stored in the same conditions at -70 0 C until subsequent processes were performed. DNA was extracted from the buccal cells using a GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, Germany) according to the manufacturer's protocol. All samples were genotyped in duplicates using an allelic discrimination assay on a Rotor-Gene real-time polymerase chain reaction (PCR) instrument (Corbett, Australia) with TaqMan probes. For the discrimination of the ADRB1 Ser49 and 49Gly alleles (rs1801252) as well as the Arg389 and 389Gly alleles (rs1801253), TaqMan ® Pre-Designed SNP Genotyping Assays were used (Applied Biosystems, USA) (assay ID: C___8898508_10 and C___8898494_10, respectively). Genotypes were assigned using all of the data from the study simultaneously.
Statistical analysis
The STATISTICA software package, version 8.0, was used to perform all statistical evaluations. Allele frequencies were determined by gene counting. A χ 2 two-sided test with Yates correction was used to compare the ADRB1 Ser49Gly and Arg389Gly alleles and genotype frequencies between athletes and control subjects. The haplotype prediction was performed using the PHASE (version 2.2) programme [14, 15] . The level of statistical significance was set at P<0.05. A FDR (false discovery rate) procedures were used to adjust for multiple comparisons using the method applied for multiple testing under dependency [16] .
Results
Genotypes were determined for 223 DNA samples of athletes and 354 DNA samples of controls -genotyping error was assessed as 1%, while the call rate (the proportion of samples in which the genotyping provided unambiguous reading) was above 95%. All genotype distributions for both athletes and controls met Hardy-Weinberg expectations (P>0.05 in all groups tested separately). The results of the distribution of alleles and genotypes for both the ADRB1 Ser49Gly and Arg389Gly markers in Polish athletes compared with the non-athletic controls (all subjects stratified by gender) are presented in Table 1 . The genotype distribution of the Ser49Gly and Arg389Gly polymorphic sites was not significantly different when all athletes, endurance athletes and power athletes were compared to sedentary controls ( Table 1) . A Yates-χ 2 test revealed that the frequency of the 389Gly allele was not significantly different between groups of athletes and controls, however it was observed that the frequency of the 49Gly allele was significantly higher in endurance athletes than in the controls (11% vs. 6.4%; P=0.026). The data showed no male-female genotype and allele frequency differences in controls and both in power and endurance athletes ( Table 1 ). The odds ratio of having the 49Gly allele (49Gly/49Gly + Ser49/49Gly genotypes) vs. Ser49/Ser49 genotype for endurance athletes was 2.00 (95% confidence interval 1.16-3.47; P=0.018). The haplotype analysis revealed that three haplotypes (Ser49:Arg389, Ser49:389Gly, 49Gly:Arg389) occur both in athletes and sedentary controls (Table 1) due to strong linkage disequilibrium between the Ser49Gly and Arg389Gly markers (D'=1 for all analysed subgroups of athletes and controls). A statistically significant excess of the 49Gly:Arg389 haplotype was observed in the endurance athletes subgroup compared to the controls (11% vs. 6.3%, P=0.048). In the Polish athletes, the odds ratio of the ADRB1 49Gly:Arg389 haplotype for endurance athletes subgroup was 1.82 (95% confidence interval 1.10-3.00; P=0.026). None of the associations described above retained the significance level of 0.05 after adjusting for multiple comparisons using the FDR methodology.
Discussion
Our study reported the frequencies of alleles and genotypes as well as haplotype distribution of the ADRB1 gene Ser49Gly and Arg389Gly polymorphisms in Polish athletes. The main findings of the study were that 1) the frequency of the 49Gly allele was significantly higher in the endurance athletes subgroup when compared with the controls, 2) a significant excess of the 49Gly:Arg389 haplotype frequency was noted in the Polish endurance athletes.
To our knowledge, this is the first report showing a positive association between endurance athlete status and the ADRB1 Ser49Gly polymorphism and the Ser49Gly:Arg389Gly haplotype. Thus, our results should be interpreted with caution and need to be replicated in similar populations. There was one attempt to correlate the Arg389Gly marker with sports performance; however, no association was found [17] . Instead, many papers have been recently published regarding the impact of the ADRB1 Ser49Gly and Arg389Gly polymorphisms on the prevalence of cardiovascular diseases and their progression in humans. The Ser49Gly polymorphism was found to be associated with the long-term survival of patients with chronic heart failure (HF), however the frequency of the Ser49Gly variants was not different between the healthy controls and patients with congestive HF or patients with idiopathic dilated cardiomyopathy [8, 18] . It was suggested that the 49Gly allele may be the potential beneficial factor in the prognosis of the disease [19] . The study investigating ADRB1 polymorphisms and their association with aerobic power or the response to physical training in patients with coronary artery disease revealed that subjects who were homozygous for the 49Gly allele had significantly higher aerobic power at baseline, and an increase in aerobic power after three months of physical training was observed [2] . An investigation by Wolfarth et al. (presented at European Society of Cardiology Congress, Vienna, Austria, 1-5 September 2007; available online at: http://spo. escardio.org/eslides/view.aspx?eevtid=19&fp=1774) involving elite endurance athletes indicated that 49Gly allele carriers displayed significantly higher values of the left ventricular mass index (LVMI) when compared to the Ser49/Ser49 genotype carriers, while no association was found between the Arg389Gly genotypes and the LVMI. Our study also indicates that the 49Gly allele was more prevalent in the group of endurance athletes. Moreover, we observed that a strong linkage disequilibrium (LD) exists between both the Ser49Gly and Arg389Gly markers, resulting in haplotypes that are defined as combinations of specific polymorphisms on one chromosome that are inherited together. Common haplotypes of the ADRB1 gene have been identified in different racial/ethnic groups and it was shown that the most prevalent haplotypes in Caucasians are Ser49:Arg389, Ser49:389Gly and 49Gly:Arg389 [20, 21] , while the haplotype 49Gly:389Gly occurs very rarely, if at all [18] . The effects of haplotypes on cardiovascular diseases were observed in several groups of patients. The prospective study of Johnson et al. [22] carried out on hypertensive patients revealed that subjects with the Ser49:Arg389 haplotype demonstrated a significant reduction in diastolic blood pressure after the administration of metoprolol, but no such effect was observed in 49Gly:Arg389 haplotype carriers. Another study evaluated the relationship between the ADRB1 haplotypes and cardiovascular risk and revealed that the death rates were higher in patients with the Ser49:Arg389 haplotype [21] . The relevance of β1AR haplotypes in exercise performance, in association with cardiac disease, was studied in patients with congestive heart failure, and it was found that 49Gly:Arg389 haplotype carriers had a higher peak of oxygen consumption compared to other haplotype carriers [3] .
In the study presented here, the overrepresentation of the 49Gly:Arg389 haplotype was observed in the group of endurance athletes. Based on the physiological data and associated medical studies mentioned above, it might be hypothesised that endurance athletes could benefit from harbouring the 49Gly:Arg389 haplotype. The molecular aspects of the Ser49Gly and Arg389Gly polymorphisms localisation and the functional relevance of the polymorphic variants explain why the 49Gly:Arg389 haplotype may influence endurance performance. It is known that the Ser49Gly polymorphism is located in the amino-terminus of the β1AR protein, which is responsible for agonist interactions [18] , while the Arg389Gly polymorphism is located in the C-terminal region of the β1 receptor within the putative G-protein binding domain critical to subsequent cell signalling; therefore, it has been suggested to be functionally important [6] . Both of the 49Gly and Arg389 variants exhibit a higher agonistinduced activation of AC [4, 19, 23] and, in the case of the Arg389 variant, a greater coupling to Gs proteins with the functional consequence of better activation of the effector mechanisms, which could favour cardiac contractility by stimulating cardiac inotropism. For that reason the 49Gly and Arg389 variants are believed to be "responsive alleles". Moreover, because both alleles are more susceptible to desensitisation and down-regulation [24, 25] , it might be suspected that 49Gly:Arg389 haplotype carriers could benefit from harbouring such an allele combination during long-term adrenergic stimulation, causing increase heart rate and contractile force as well as vasodilation. This results in increase in cardiac output, reduction in peripheral vascular resistance and increased blood flow into the working muscles; all of these mechanisms are required for performing prolonged exertion.
In conclusion, our study has reported evidence that the Ser49Gly, but not the Arg389Gly, markers of the ADRB1 gene and one haplotype combination of both polymorphisms are associated with endurance athlete status and probably influence the endurance performance in Polish athletes. The studied ADRB1 genetic variants alone do not seem to be sufficient to determine endurance phenotype, but they likely modulate physiological factors and contribute to the polygenic profile of the endurance athlete. It appears that the 49Gly variant and/or the 49Gly:Arg389 haplotype have a beneficial effect on sports performance by enhancing cardiovascular function. Thus, it might be stated that 1) the ADRB1 gene is a candidate to understand individual variations in health and exercise related phenotypes, 2) the 49Gly allele and the 49Gly:Arg389 haplotype of the ADRB1 gene might favour endurance sport performance, and 3) the Arg389Gly polymorphic site alone does not seem to influence endurance sports performance.
Our study is limited by several factors. As a genetic association study, these results should be interpreted with caution. Because it is the first report regarding association between endurance athlete status and the ADRB1 Ser49Gly polymorphism and the Ser49Gly:Arg389Gly haplotype it needs to be replicated in similar populations to obtain valid results. The fact that none of the described associations remained significant after correcting for multiple comparisons needs to be emphasized. The reasons for the lack of significance between the analysed SNPs and endurance athlete status may result from the limited number of endurance athletes that were analysed in our study. The size of our athlete group is relatively small, which decreases the statistical power of the analyses. However, considering that there is a limited number of elite athletes worldwide and also in Poland, we were unable to gather additional samples for this population. The lack of significance following FDR may also indicate that described genetic associations between ADRB1 Ser49Gly polymorphism, haplotype combination and endurance athlete phenotype represent a chance occurrence only and is not actually causative mechanism determining endurance performance. There might also be other genetic variants within or near the studied gene that influence athletic performance in complex interactions. It is worth noting that the epigenetic mechanisms that change the gene function are equally as important as genetic variations in the DNA sequence when determining the elite athletic phenotype. Thus, additional large-scale prospective studies involving the interactions mentioned above are needed.
